Novel CTCF mutations in Chinese patients with ovarian endometriosis

  • Authors:
    • Jiubai Guo
    • Bianna Cao
    • Xiaoyun Xu
    • Fei Wu
    • Bin Zhu
  • View Affiliations

  • Published online on: May 22, 2018     https://doi.org/10.3892/mmr.2018.9049
  • Pages: 1031-1036
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Endometriosis is a common gynecological disease characterized by the outgrowth of the endometrium, however, the detailed molecular etiology remains largely uncharacterized. Recent studies have implicated that endometriosis is potentially a precancerous lesion, and that CCCTC‑binding factor (CTCF) mutations may be involved in the pathogenesis of this disorder. However, the detailed CTCF mutation spectrum in Chinese patients with ovarian endometriosis remains largely unknown. In the present study, a cohort of 92 patients with ovarian endometriosis were analyzed for the presence of CTCF mutations by sequencing the entire coding regions. In addition, 67 healthy eutopic endometrial tissues and 46 healthy ovarian tissues from control samples (without endometriosis) were also analyzed. In total, two CTCF missense mutations, p.K206E (c.616A>G) and p.H373L (c.1118A>T), were identified in 2/92 (2.2%) endometriotic lesions. The patient with the p.K206E mutation was 26 years old and diagnosed with primary infertility, whereas the patient with the p.H373L mutation was 37 years old and concurrently diagnosed with uterine leiomyoma. The p.H373L mutation was previously identified in endometrial cancer samples with low frequency, while the p.K206E mutation was novel. In addition, no CTCF mutations were detected in the 67 healthy eutopic endometrial and 46 healthy ovarian tissue samples. In silico prediction and evolutionary conservation analysis suggested that these CTCF mutations may be pathogenic. In summary, the present study identified 2 potential pathogenic CTCF mutations in endometriotic lesions from 2/92 patients with ovarian endometriosis. These results, together with a prior exome‑sequencing based study, suggest that CTCF mutations may be involved in the development of ovarian endometriosis.
View Figures
View References

Related Articles

Journal Cover

July-2018
Volume 18 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Guo J, Cao B, Xu X, Wu F and Zhu B: Novel CTCF mutations in Chinese patients with ovarian endometriosis. Mol Med Rep 18: 1031-1036, 2018
APA
Guo, J., Cao, B., Xu, X., Wu, F., & Zhu, B. (2018). Novel CTCF mutations in Chinese patients with ovarian endometriosis. Molecular Medicine Reports, 18, 1031-1036. https://doi.org/10.3892/mmr.2018.9049
MLA
Guo, J., Cao, B., Xu, X., Wu, F., Zhu, B."Novel CTCF mutations in Chinese patients with ovarian endometriosis". Molecular Medicine Reports 18.1 (2018): 1031-1036.
Chicago
Guo, J., Cao, B., Xu, X., Wu, F., Zhu, B."Novel CTCF mutations in Chinese patients with ovarian endometriosis". Molecular Medicine Reports 18, no. 1 (2018): 1031-1036. https://doi.org/10.3892/mmr.2018.9049